查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1933829

心血管手术耗材市场按产品类型、手术类型、应用、最终用户和分销管道划分，全球预测（2026-2032年）

Cardiac Surgery Consumables Market by Product Type, Procedure Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，心臟外科耗材市场价值将达到 24.4 亿美元，到 2026 年将成长至 25.9 亿美元，到 2032 年将达到 36.8 亿美元，年复合成长率为 6.07%。

关键市场统计数据
基准年 2025 24.4亿美元
预计年份：2026年 25.9亿美元
预测年份 2032 36.8亿美元
复合年增长率 (%) 6.07%

对心臟外科耗材生态系统进行详细概述，重点在于临床需求、营运驱动因素和创新主导的采购要求。

心臟外科耗材市场面临临床技术日益复杂、供应链日益繁琐以及法律规范。医院和门诊手术中心依赖各种一次性耗材和辅助产品来支援心胸外科手术，而器械设计和材料科学的不断进步也持续改变术中操作流程。外科医生和循环系统寻求能够优化患者安全、缩短手术时间并降低併发症风险的解决方案，而采购和临床工程部门则优先考虑库存优化、可追溯性和成本效益。

生物材料、器械设计和医疗服务模式的创新如何重塑心臟外科手术耗材的选择和筹资策略

心臟外科耗材领域正经历着变革性的转变，其驱动力包括临床创新、材料科学的突破以及不断发展的诊疗路径。生物材料和微加工技术的进步使得氧合器和动脉过滤器更加紧凑高效，旨在减少预充量和血液损伤。改良的密封剂化学成分和缝合技术提高了止血可靠性，从而缩短了手术时间并减少了术后介入。这些技术进步并非孤立存在，而是与更广泛的趋势相互作用，例如微创和混合手术的兴起，这些趋势需要配置更完善的手术包和更精简的器械套装。

近期关税调整使心臟外科耗材筹资策略、库存计画和供应商关係变得更加复杂。

关税的实施为参与跨大西洋和跨太平洋供应链的心臟外科耗材采购的相关人员带来了新的复杂性。关税调整不仅影响到岸成本，还会影响库存管理实务、关键物资储备的资本规划，以及本地生产与进口依赖的经济效益。为此，医院供应链负责人正在重新评估其筹资策略和库存政策，以在应对预算压力的同时，确保医疗服务的连续性。一些机构正在增加氧合器和缝合线等关键部件的安全库存，而另一些机构则在与国内供应商和区域经销商谈判长期合同，以降低贸易相关成本波动带来的风险。

全面的細項分析揭示了产品类别、临床应用、最终用户、分销模式和手术类型如何决定耗材的选择。

了解产品细分的细微差别对于解读心臟外科耗材的需求驱动因素和采用模式至关重要。产品类型涵盖动脉过滤器、插管、心臟麻痹液、氧合器、手术补片、缝线和组织黏合剂等，每种产品都有不同的临床应用和采购考量。动脉过滤器进一步分为微孔过滤器和血浆分离器，以满足特定的灌注策略和患者风险状况。插管根据解剖位置和可耐受的动态分为动脉插管和静脉插管。心臟麻痹液分为血液基溶液和晶体溶液，这会影响心臟停搏策略和灌注师的选择。体外循环机分为中空纤维型和膜型，每种类型在气体交换效率和血液相容性方面各有优劣。手术补片有生物基和合成材料两种；生物基补片适用于生物完整性至关重要的场合，而合成补片适用于需要可预测机械性质的场合。缝合线材料依创伤治疗时间和组织反应的差异，分为可吸收缝合线和不可吸收缝合线。组织密封胶分为纤维蛋白基密封剂和合成化学密封剂，其选择通常取决于出血情况以及与抗凝血剂的相互作用。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势和实践差异正在推动招募和筹资策略的差异化。

区域趋势显着影响心臟外科耗材的临床实务模式、监管预期和采购模式。在美洲，许多成熟的卓越中心和先进的外科手术计画形成了一个庞大的市场，导致对高复杂度耗材的需求集中，并促使人们频繁采用渐进式创新技术。报销结构和医院整合趋势进一步影响采购行为，整合医疗网络通常寻求标准化的耗材包和基于用量的合同，以实现可预测的成本和临床一致性。

竞争格局概述：製造商和经销商如何透过临床支援、法规应对力和综合价值提案实现差异化竞争

产业参与者包括专业製造商、多元化医疗设备公司和区域批发商，其能力涵盖产品设计、法规事务、生产製造和临床教育。领先的供应商强调整合价值提案，将高性能耗材与外科团队和体外循环人员的培训计画相结合，因为他们认识到，临床对新产品的信心往往取决于教育和实践支援。投资于品质系统和上市后监测的製造商能够更容易地满足日益严格的可追溯性和不利事件报告监管要求，从而在医疗设备受到严格审查的市场中获得竞争优势。

为製造商和医疗系统领导者提供可操作的策略指南，以协调创新、供应链韧性和临床医生采纳路径

该领域的领导者必须采取多管齐下的策略，使产品创新与营运实际情况和不断发展的临床实践相契合。首先，优先开发能够显着降低患者风险和手术复杂性的产品，并专注于血液相容性、易用性和与微创工作流程的兼容性。其次，透过资助实用性研究和真实世界证据收集，加强临床证据的生成，这些研究和证据能够直接与关注治疗效果和总成本的机构决策者对话。第三，透过分散製造地、建立区域分销中心以及提供灵活的合约条款来应对价格波动和前置作业时间不确定性，从而增强供应链的韧性。

我们采用透明的多学科研究方法，将临床医生的第一手见解与二手技术文献结合，以确保分析的严谨性和可靠性。

本报告整合了透过结构化、多维度研究方法收集的定性和定量信息，旨在确保研究的严谨性和相关性。主要研究包括对临床专家、循环系统护理师、采购人员和供应链经理的访谈，以了解他们对产品表现、操作流程偏好和购买行为的现场观点。次要研究则涉及对同行评审的临床文献、监管指导文件、医疗设备标籤检视和技术白皮书的广泛审查，以检验产品属性和安全注意事项。

对临床、营运和策略方面的影响进行简明扼要的综合分析，从而界定耗材的可持续价值和推广路径。

心臟外科耗材是一个复杂的领域，它整合了临床需求、技术进步和供应链管理。临床团队需要能够改善患者预后并简化术中流程的产品，而采购和营运负责人则需要可预测性、合规性和成本效益。最成功的供应商将是那些能够将产品创新与可证实的临床效益相结合、提供强有力的实施支持并维持能够应对市场波动的弹性分销模式的供应商。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章心血管手术耗材市场（依产品类型划分）

  • 动脉滤器
    • 微孔
    • 等离子分离器
  • 套管
    • 动脉
    • 静脉注射用
  • 心臟麻痹液
    • 血液
    • 晶体溶液
  • 人工肺
    • 中空纤维膜
    • 电影
  • 手术补片
    • 生物斑块
    • 合成补丁
  • 缝合材料
    • 吸收性
    • 不可吸收
  • 组织密封剂
    • 纤维蛋白胶
    • 合成密封剂

第九章 依手术类型分類的心血管手术耗材市场

  • 非泵送
  • 泵浦上

第十章 按应用分類的心血管手术耗材市场

  • 动脉瘤修復
  • 矫正先天缺陷
  • 冠状动脉绕道手术手术
  • 心臟移植
  • 阀门维修和更换

第十一章心血管手术耗材市场（依最终用户划分）

  • 门诊手术中心
  • 医院

第十二章心血管手术耗材市场（依通路划分）

  • 直销
  • 批发商

第十三章 各地区心血管手术耗材市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章心血管手术耗材市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国心血管手术耗材市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国心血管手术耗材市场

第十七章：中国心血管手术耗材市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • Abiomed, Inc.
  • Angiodynamics, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Braile Biomedica
  • Canon Medical Systems Asia Pte. Ltd.
  • Cardinal Health
  • Cook Medical
  • Edwards Lifesciences Corporation
  • GE HealthCare
  • Getinge AB
  • ICU Medical, Inc.
  • LivaNova PLC
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NovoSci
  • Remington Medical
  • Sorin SpA
  • Surge Cardiovascular
  • Teleflex Incorporated
  • Terumo Corporation
  • Tianjin Medical
  • Transmedics
  • WL Gore & Associates, Inc.
Product Code: MRR-C36616F6996A

The Cardiac Surgery Consumables Market was valued at USD 2.44 billion in 2025 and is projected to grow to USD 2.59 billion in 2026, with a CAGR of 6.07%, reaching USD 3.68 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.44 billion
Estimated Year [2026] USD 2.59 billion
Forecast Year [2032] USD 3.68 billion
CAGR (%) 6.07%

An in-depth orientation to the cardiac surgery consumables ecosystem emphasizing clinical demands, operational drivers, and innovation-led procurement imperatives

The cardiac surgery consumables landscape operates at the intersection of clinical sophistication, supply chain complexity, and regulatory oversight. Hospitals and ambulatory surgical centers rely on a broad assortment of disposables and adjunctive products to support cardiothoracic procedures, and incremental improvements in device design and materials science have steadily reshaped intraoperative practice. Surgeons and perfusionists demand solutions that optimize patient safety, minimize operative time, and reduce complication risk, while procurement and clinical engineering teams prioritize inventory rationalization, traceability, and cost-effectiveness.

Over the last decade, there has been an evolving emphasis on devices that deliver predictable performance under high-stakes conditions. Innovations in filtration media, oxygenator membrane technology, and biocompatible sealants have aimed to reduce inflammatory responses and improve hemostasis. Concurrently, procedural shifts driven by advances in minimally invasive techniques and on-pump versus off-pump strategies influence which consumables are used and when. Policy and reimbursement environments impose another layer of constraint that institutions must navigate when adopting new supplies.

Taken together, these forces create a dynamic environment where clinical efficacy, operational efficiency, and regulatory compliance determine which products gain traction. Decision-makers are increasingly looking for evidence of comparative performance and lifecycle value rather than focusing solely on unit price. As a result, manufacturers and suppliers that align product development with clinician needs and institutional priorities stand to build more resilient adoption pathways.

How innovations in biomaterials, device design, and care delivery models are reshaping consumables selection and procurement strategies in cardiac surgery

The landscape of cardiac surgery consumables is undergoing transformative shifts driven by clinical innovation, material science breakthroughs, and evolving care pathways. Advances in biomaterials and microfabrication have enabled more compact, efficient oxygenators and arterial filters that aim to lower priming volumes and reduce blood trauma. Improvements in sealant chemistries and suture technologies are enhancing hemostatic reliability, which in turn supports shorter operative times and fewer postoperative interventions. These technological strides are not isolated; they interact with broader trends such as the move toward minimally invasive and hybrid procedures that demand differently configured kits and streamlined instrument sets.

At the same time, healthcare systems are intensifying scrutiny of perioperative outcomes and cost-to-care metrics, prompting hospitals to prefer products that demonstrate clear clinical benefit and integration into standardized care pathways. Supply chain resilience has become a strategic priority, accelerating interest in diversified distribution models and closer collaboration between manufacturers and large health systems. Regulatory emphasis on device traceability and post-market surveillance is raising the bar for product documentation and quality systems, especially for biological patches and tissue-derived materials. Collectively, these shifts favor suppliers that can demonstrate both clinical differentiation and operational compatibility with institutional workflows.

How recent tariff changes have complicated sourcing strategies, inventory planning, and supplier relationships across cardiac surgery consumables

The imposition of tariffs has introduced a new dimension of complexity for stakeholders sourcing cardiac surgery consumables that are part of transatlantic and transpacific supply chains. Tariff adjustments affect not only landed cost but also inventory practices, capital planning for stocking critical items, and the economics of localized manufacturing versus import reliance. In response, hospital supply chain leaders have revisited sourcing strategies and inventory policies to maintain continuity of care while managing budgetary pressures. Some organizations have increased safety stock for critical components such as oxygenators and suture materials, while others have negotiated longer-term contracts with domestic suppliers or regional distributors to mitigate exposure to trade-related cost volatility.

The ripple effects extend to clinical decision-making where product substitution decisions require careful validation to ensure equivalence in performance. Purchasing teams are collaborating more closely with clinical stakeholders to evaluate potential switches, focusing on clinical evidence and operational implications rather than price alone. Simultaneously, suppliers are adapting by reassessing pricing models, localizing parts of their manufacturing footprint, or optimizing logistics to shorten lead times. Even where tariffs have stabilized, the broader lesson for industry participants has been the strategic value of supply chain flexibility and proactive scenario planning to preserve clinical continuity and protect margins.

Comprehensive segmentation analysis revealing how product classes, clinical applications, end users, distribution models, and procedure types determine consumable choices

A nuanced understanding of product segmentation is essential to interpret demand drivers and adoption patterns across cardiac surgery consumables. Product types span arterial filters, cannulas, cardioplegia solutions, oxygenators, surgical patches, suture materials, and tissue sealants, each carrying distinct clinical roles and procurement considerations. Arterial filters further differentiate across microporous and plasma separators, which cater to particular perfusion strategies and patient risk profiles. Cannulas are classified as arterial or venous, reflecting their anatomical placement and the flow dynamics they must withstand, while cardioplegia solutions divide into blood-based and crystalloid formulations that influence myocardial protection strategies and perfusionist preferences. Oxygenators can be distinguished by hollow fiber and membrane designs, each offering trade-offs in gas exchange efficiency and hemocompatibility. Surgical patches exist as biological versus synthetic options, with biological patches appealing where host integration is prioritized and synthetic patches favored where predictable mechanical properties are required. Suture materials bracket absorbable and non-absorbable types, aligning with differing wound-healing timelines and tissue responses. Tissue sealants split into fibrin-based and synthetic chemistries, and selection often hinges on bleeding profile and interaction with anticoagulation.

Application-based segmentation maps to the clinical procedures that determine consumption patterns. Aneurysm repair, congenital defect correction, coronary artery bypass graft, heart transplant, and valve repair and replacement each drive specific needs for device configurations, sizes, and adjuncts. End-user segmentation distinguishes ambulatory surgical centers from hospitals, recognizing that procedural complexity, case mix, and procurement authority differ markedly between these settings. Distribution channels also vary, with direct sales relationships enabling closer clinical support and customized supply agreements, while distributors provide reach and logistical scale. Finally, procedure type-off pump versus on pump-affects the choice and quantity of consumables, influencing perfusion-related items and hemostatic adjuncts. By viewing segmentation holistically, stakeholders can align product development, clinical training, and commercial strategies to the nuanced demands of each submarket.

Regional dynamics and practice heterogeneity across the Americas, Europe Middle East & Africa, and Asia-Pacific that drive differentiated adoption and procurement strategies

Regional dynamics exert significant influence on clinical practice patterns, regulatory expectations, and procurement models for cardiac surgery consumables. In the Americas, established centers of excellence and a large installed base of advanced surgical programs create concentrated demand for higher-complexity consumables and frequent adoption of incremental innovations. Reimbursement structures and hospital consolidation trends further shape purchasing behavior, with integrated delivery networks often seeking standardized kits and volume-based contracting to achieve predictable costs and clinical consistency.

Across Europe, Middle East & Africa, heterogeneity in regulatory regimes and resource availability leads to divergent adoption timelines for novel products. Western European markets favor rigorous clinical evidence and tend to pilot new technologies within tertiary centers before broader roll-out, whereas parts of the Middle East and Africa may prioritize supply reliability and value-based procurement given differing infrastructure constraints. These contrasts require manufacturers to tailor market access strategies, regulatory submissions, and educational outreach to local needs.

The Asia-Pacific region combines rapid capacity expansion in tertiary care with diverse procurement models. Several markets display accelerated adoption of minimally invasive and hybrid procedures, which elevates demand for specialized consumables and creates opportunities for partnerships focused on training and clinical support. At the same time, local manufacturing capabilities and policy preferences for domestic sourcing influence supplier entry strategies. Across all regions, the interplay of clinical practice evolution, regulatory pathways, and procurement sophistication will determine how quickly innovations move from niche use to routine adoption.

Competitive landscape overview highlighting how manufacturers and distributors differentiate through clinical support, regulatory strength, and integrated value propositions

Industry participants include a range of specialized manufacturers, diversified medical device firms, and regional distributors whose capabilities span product design, regulatory affairs, manufacturing, and clinical education. Leading suppliers emphasize integrated value propositions that combine high-performance consumables with training programs for surgical teams and perfusion staff, recognizing that clinical confidence in new products often depends on education and real-world support. Manufacturers investing in quality systems and post-market surveillance can more readily meet tightening regulatory expectations for traceability and adverse event reporting, which becomes a competitive advantage in markets with stringent device oversight.

Strategic partnerships and targeted acquisitions have proven effective routes for expanding product portfolios and geographic reach. Collaborations with academic centers and key opinion leaders help validate product performance and accelerate clinical acceptance. At the distribution level, companies that provide logistic resilience, inventory management solutions, and contract flexibility appeal to large health systems seeking to mitigate supply chain risk. Additionally, a growing emphasis on sustainability and environmental stewardship has prompted some firms to optimize packaging and waste management practices for disposables, which resonates with institutional purchasing policies that include environmental criteria alongside clinical and economic considerations.

Actionable strategic directives for manufacturers and health system leaders to align innovation, supply resilience, and clinician adoption pathways

Leaders in the field must adopt a multi-pronged strategy that aligns product innovation with operational realities and evolving clinical practice. First, prioritize development efforts that demonstrably reduce patient risk and procedural complexity, focusing on hemocompatibility, ease of use, and compatibility with minimally invasive workflows. Second, strengthen clinical evidence generation by sponsoring pragmatic studies and real-world evidence collection that speak directly to institutional decision-makers concerned with outcomes and total cost of care. Third, enhance supply chain resilience by diversifying manufacturing footprints, establishing regional distribution hubs, and offering flexible contract terms that help customers manage price volatility and lead time uncertainty.

Additionally, invest in clinician education and implementation support to shorten the adoption curve for new products. Tailored training modules, in-procedure support, and collaborative quality-improvement initiatives increase clinical confidence and help integrate consumables into standardized care bundles. From a commercial perspective, explore outcome-based or value-aligned contracting models that better share risk and reward with healthcare purchasers. Finally, prioritize compliance and post-market surveillance capabilities to satisfy regulatory demands and build long-term trust; these steps will position manufacturers and distributors to respond more nimbly to changes in clinical practice and policy environments.

A transparent, multi-source research approach combining primary clinician insights and secondary technical literature to ensure rigorous analysis and credibility

This report synthesizes qualitative and quantitative inputs gathered through a structured, multi-source research approach designed to ensure rigor and relevance. Primary research includes interviews with clinical experts, perfusionists, procurement leaders, and supply chain managers to capture frontline perspectives on product performance, procedural preferences, and purchasing behavior. Secondary research encompasses a thorough review of peer-reviewed clinical literature, regulatory guidance documents, device labeling, and technical whitepapers to validate product characteristics and safety considerations.

Analytical methods integrate cross-validation between primary insights and documented evidence, and thematic analysis was applied to identify recurrent drivers of adoption, barriers to uptake, and emergent clinical trends. Comparative product profiling assessed design features, materials, and operational implications across device classes. Regional and procedural variations were examined through a combination of expert testimony and jurisdictional policy review. Throughout the research process, emphasis remained on transparency of assumptions, traceability of source material, and iterative stakeholder review to ensure findings reflect both clinical realities and operational constraints.

A concise synthesis of clinical, operational, and strategic implications that determine the enduring value and adoption pathways for consumables

Cardiac surgery consumables represent a complex interplay of clinical necessity, technological evolution, and supply chain management. Clinical teams seek products that enhance patient outcomes and streamline intraoperative workflows, while procurement and operational leaders demand predictability, compliance, and cost efficiency. The most successful suppliers will be those that align product innovation with demonstrable clinical benefit, provide robust implementation support, and maintain resilient distribution models that can absorb market shocks.

Looking ahead, the pace of incremental innovation in biomaterials and device design will continue to influence consumables selection, but adoption will be mediated by evidence generation, regulatory clarity, and supply chain agility. Stakeholders that invest in collaborative evidence collection, clinician education, and flexible commercialization models will be best positioned to translate technological advances into widespread clinical practice. In summary, managing the intersection of clinical performance, operational feasibility, and policy constraints will determine which products and companies emerge as durable partners for health systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cardiac Surgery Consumables Market, by Product Type

  • 8.1. Arterial Filters
    • 8.1.1. Microporous
    • 8.1.2. Plasma Separators
  • 8.2. Cannulas
    • 8.2.1. Arterial
    • 8.2.2. Venous
  • 8.3. Cardioplegia Solutions
    • 8.3.1. Blood Based
    • 8.3.2. Crystalloid
  • 8.4. Oxygenators
    • 8.4.1. Hollow Fiber
    • 8.4.2. Membrane
  • 8.5. Surgical Patches
    • 8.5.1. Biological Patches
    • 8.5.2. Synthetic Patches
  • 8.6. Suture Materials
    • 8.6.1. Absorbable
    • 8.6.2. Non Absorbable
  • 8.7. Tissue Sealants
    • 8.7.1. Fibrin Sealants
    • 8.7.2. Synthetic Sealants

9. Cardiac Surgery Consumables Market, by Procedure Type

  • 9.1. Off Pump
  • 9.2. On Pump

10. Cardiac Surgery Consumables Market, by Application

  • 10.1. Aneurysm Repair
  • 10.2. Congenital Defect Correction
  • 10.3. Coronary Artery Bypass Graft
  • 10.4. Heart Transplant
  • 10.5. Valve Repair And Replacement

11. Cardiac Surgery Consumables Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals

12. Cardiac Surgery Consumables Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors

13. Cardiac Surgery Consumables Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Cardiac Surgery Consumables Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Cardiac Surgery Consumables Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Cardiac Surgery Consumables Market

17. China Cardiac Surgery Consumables Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 3M Company
  • 18.6. Abiomed, Inc.
  • 18.7. Angiodynamics, Inc.
  • 18.8. B. Braun Melsungen AG
  • 18.9. Baxter International Inc.
  • 18.10. BIOTRONIK SE & Co. KG
  • 18.11. Boston Scientific Corporation
  • 18.12. Braile Biomedica
  • 18.13. Canon Medical Systems Asia Pte. Ltd.
  • 18.14. Cardinal Health
  • 18.15. Cook Medical
  • 18.16. Edwards Lifesciences Corporation
  • 18.17. GE HealthCare
  • 18.18. Getinge AB
  • 18.19. ICU Medical, Inc.
  • 18.20. LivaNova PLC
  • 18.21. Medtronic plc
  • 18.22. MicroPort Scientific Corporation
  • 18.23. NovoSci
  • 18.24. Remington Medical
  • 18.25. Sorin S.p.A.
  • 18.26. Surge Cardiovascular
  • 18.27. Teleflex Incorporated
  • 18.28. Terumo Corporation
  • 18.29. Tianjin Medical
  • 18.30. Transmedics
  • 18.31. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CARDIAC SURGERY CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CARDIAC SURGERY CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL FILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL FILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL FILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL FILTERS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY MICROPOROUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY MICROPOROUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY MICROPOROUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PLASMA SEPARATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PLASMA SEPARATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PLASMA SEPARATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CANNULAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CANNULAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CANNULAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CANNULAS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY VENOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY VENOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY VENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CARDIOPLEGIA SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CARDIOPLEGIA SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CARDIOPLEGIA SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CARDIOPLEGIA SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY BLOOD BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY BLOOD BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY BLOOD BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CRYSTALLOID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CRYSTALLOID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CRYSTALLOID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OXYGENATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OXYGENATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OXYGENATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY HOLLOW FIBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY HOLLOW FIBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY HOLLOW FIBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY MEMBRANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY MEMBRANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY MEMBRANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SURGICAL PATCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SURGICAL PATCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SURGICAL PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY BIOLOGICAL PATCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY BIOLOGICAL PATCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY BIOLOGICAL PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SYNTHETIC PATCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SYNTHETIC PATCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SYNTHETIC PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUTURE MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUTURE MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUTURE MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUTURE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY NON ABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY NON ABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY NON ABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY TISSUE SEALANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY TISSUE SEALANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY TISSUE SEALANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY TISSUE SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY FIBRIN SEALANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY FIBRIN SEALANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SYNTHETIC SEALANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SYNTHETIC SEALANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SYNTHETIC SEALANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OFF PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OFF PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OFF PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ON PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ON PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ON PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ANEURYSM REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ANEURYSM REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ANEURYSM REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CONGENITAL DEFECT CORRECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CONGENITAL DEFECT CORRECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CONGENITAL DEFECT CORRECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY HEART TRANSPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY HEART TRANSPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY HEART TRANSPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY VALVE REPAIR AND REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY VALVE REPAIR AND REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY VALVE REPAIR AND REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL FILTERS, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CANNULAS, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CARDIOPLEGIA SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUTURE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY TISSUE SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL FILTERS, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CANNULAS, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CARDIOPLEGIA SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUTURE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY TISSUE SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL FILTERS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CANNULAS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CARDIOPLEGIA SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUTURE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY TISSUE SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL FILTERS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CANNULAS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CARDIOPLEGIA SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUTURE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY TISSUE SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL FILTERS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CANNULAS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CARDIOPLEGIA SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUTURE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY TISSUE SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL FILTERS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CANNULAS, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CARDIOPLEGIA SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUTURE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY TISSUE SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL FILTERS, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CANNULAS, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CARDIOPLEGIA SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUTURE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY TISSUE SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL FILTERS, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CANNULAS, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CARDIOPLEGIA SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUTURE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY TISSUE SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL FILTERS, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CANNULAS, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CARDIOPLEGIA SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUTURE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY TISSUE SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. GCC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. GCC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. GCC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL FILTERS, 2018-2032 (USD MILLION)
  • TABLE 232. GCC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CANNULAS, 2018-2032 (USD MILLION)
  • TABLE 233. GCC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CARDIOPLEGIA SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 234. GCC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 235. GCC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 236. GCC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUTURE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 237. GCC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY TISSUE SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 238. GCC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. GCC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. GCC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. GCC CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL FILTERS, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CANNULAS, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CARDIOPLEGIA SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUTURE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY TISSUE SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL FILTERS, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CANNULAS, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CARDIOPLEGIA SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUTURE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY TISSUE SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 268. G7 CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 269. G7 CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. G7 CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL FILTERS, 2018-2032 (USD MILLION)
  • TABLE 271. G7 CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CANNULAS, 2018-2032 (USD MILLION)
  • TABLE 272. G7 CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CARDIOPLEGIA SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 273. G7 CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 274. G7 CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 275. G7 CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUTURE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 276. G7 CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY TISSUE SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 277. G7 CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. G7 CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. G7 CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. G7 CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 281. NATO CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 282. NATO CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. NATO CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL FILTERS, 2018-2032 (USD MILLION)
  • TABLE 284. NATO CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CANNULAS, 2018-2032 (USD MILLION)
  • TABLE 285. NATO CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CARDIOPLEGIA SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 286. NATO CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 287. NATO CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 288. NATO CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUTURE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 289. NATO CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY TISSUE SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 290. NATO CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. NATO CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 292. NATO CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 293. NATO CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 294. GLOBAL CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES CARDIAC SURGERY CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED STATES CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY ARTERIAL FILTERS, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED STATES CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CANNULAS, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED STATES CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY CARDIOPLEGIA SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED STATES CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED STATES CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED STATES CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY SUTURE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED STATES CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY TISSUE SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES CARDIAC SURGERY CONSUMABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

TAB